Insights on the Ophthalmic Packaging Global Market to 2028 - Increasing Prevalence of Ocular Disorders is Driving Growth
30 sept. 2021 04h18 HE
|
Research and Markets
Dublin, Sept. 30, 2021 (GLOBE NEWSWIRE) -- The "Ophthalmic Packaging Market Size, Share & Trends Analysis Report By Dose (Single Dose, Multi Dose), By Type (OTC, Prescription), By Material...
AXIM® Biotechnologies Appoints Joseph Tauber, MD, Chief Medical Officer and Chairman of its Medical Advisory Board
21 sept. 2021 09h00 HE
|
AXIM BIOTECHNOLOGIES, INC
SAN DIEGO, Sept. 21, 2021 (GLOBE NEWSWIRE) -- AXIM Biotechnologies, Inc. (OTCQB: AXIM) (“AXIM® Biotech,” or “the Company”), an international healthcare solutions company targeting oncological,...
Europe Dry Eye Market Research and Competitive Landscape Report 2021
20 sept. 2021 04h53 HE
|
Research and Markets
Dublin, Sept. 20, 2021 (GLOBE NEWSWIRE) -- The "Europe Dry Eye Market and Competitive Landscape - 2021" report has been added to ResearchAndMarkets.com's offering. Europe Dry Eye Market and...
AXIM® Biotechnologies to Acquire Technology Including Two FDA-Cleared 510(k)’s for Diagnostic Testing of Dry Eye Disease
03 août 2021 09h00 HE
|
AXIM BIOTECHNOLOGIES, INC
SAN DIEGO, Aug. 03, 2021 (GLOBE NEWSWIRE) -- AXIM® Biotechnologies, Inc. (OTCQB: AXIM) (“AXIM® Biotech,” “AXIM” or “the Company”), a leader in the development of diagnostic testing for COVID-19 and...
Merakris Announces Agreement With Miracles In Sight Eye Bank To Supply Opticyte® Repair Grafts to Eye Surgeons
20 juil. 2021 06h30 HE
|
Merakris Therapeutics
RESEARCH TRIANGLE PARK, N.C., July 20, 2021 (GLOBE NEWSWIRE) -- Research Triangle Park-based biotechnology company Merakris Therapeutics has reached an agreement with Miracles In Sight (MIS) to...
Outlook on the Artificial Tears Global Market to 2028 - by Type, Delivery Mode, Application and Geography
12 juil. 2021 05h13 HE
|
Research and Markets
Dublin, July 12, 2021 (GLOBE NEWSWIRE) -- The "Artificial Tears Market Forecast to 2028 - COVID-19 Impact and Global Analysis by Type, Delivery Mode, and Application" report has been added to...
Dry Eye Disease Clinical Landscape Report 2021: Novartis Leads Industry Sponsors with the Highest Overall Number of Clinical Trials, Followed by AbbVie
08 juil. 2021 07h08 HE
|
Research and Markets
Dublin, July 08, 2021 (GLOBE NEWSWIRE) -- The "Market Spotlight: Dry Eye Disease" report has been added to ResearchAndMarkets.com's offering. This Market Spotlight report covers the Systemic Lupus...
Outlook on the Dry Eye Disease (DED) Global Market to 2026 - Featuring Johnson & Johnson, Bausch Health and Alcon Among Others
29 avr. 2021 05h13 HE
|
Research and Markets
Dublin, April 29, 2021 (GLOBE NEWSWIRE) -- The "Global Dry Eye Disease (DED) Market - Analysis By Disease (Aqueous, Evaporative, Others), Treatment, End User, Distribution Channel, By Region, By...
Tarsus Pharmaceuticals, Inc. to Present at the Jefferies Virtual London Healthcare Conference
13 nov. 2020 19h35 HE
|
Tarsus Pharmaceuticals, Inc
IRVINE, Calif., Nov. 13, 2020 (GLOBE NEWSWIRE) -- Tarsus Pharmaceuticals, Inc. (“Tarsus” NASDAQ: TARS), a late clinical-stage biopharmaceutical company whose mission is to discover and deliver...
I-MED Pharma launches tearcheck® in Canada - A new standard in dry eye analysis
10 nov. 2020 10h20 HE
|
I-MED Pharma
MONTREAL, Nov. 10, 2020 (GLOBE NEWSWIRE) -- I-MED Pharma Inc., a Canadian company specializing in dry eye diagnosis and management, announces the launch of tearcheck®, a new Health Canada approved...